BB Healthcare Trust plc (the "Company")

LEI: 213800HQ3J3H9YF2UI82

Statement re: Target total dividend for the financial year ending 30 November 2022

As stated in the Company's IPO prospectus and in the Company's prospectus dated 5 November 2018, the Company aims to target a dividend each financial year equal to 3.5 per cent of the Net Asset Value as at the last day of the Company's preceding financial year.

The Company intends to pay dividends on a semi-annual basis, by way of two equal dividends, with dividends declared in July and paid in August / September and proposed in February / March and paid in March / April in each year.

For the financial year ended 30 November 2021 the Company paid an interim dividend of 3.015p per ordinary share in September 2021 and in due course the Board is intending to propose a final dividend of 3.015p per ordinary share.

For the financial year ending 30 November 2022, the target total dividend will be 6.47p per ordinary share, this being 3.5 per cent of the unaudited net asset value per ordinary share of 184.91p per ordinary share (including current financial year revenue items) as at 30 November 2021. The Board intends to declare an interim dividend of 3.235p per ordinary share, being half of the target total dividend for the financial year ending 30 November 2022, in July 2022 and intends to pay this dividend in August / September 2022. The Board intends to propose a final dividend of 3.235p per ordinary share for the financial year ending 30 November 2022, in February / March 2023 and intends to pay this dividend in March / April 2023.

Randeep Grewal, Chairman, commented:

The Board is pleased to announce that this is the fifth consecutive year of dividend growth for the Company, with an 84.9% increase in distributions over the past five years and a 7.3% increase on last year's level of distribution.

Shareholders will again be offered the opportunity to participate in the Scrip Dividend Scheme and elect for their cash dividend to be automatically subscribed on their behalf for new ordinary shares. Shareholders who do not elect to participate in the Scrip Dividend Scheme will receive their dividends in cash.

The Company pays dividends from a combination of available net income during the financial year and other distributable reserves. It is currently anticipated that most of the target dividend for the financial year ending 30 November 2022 will be financed from other distributable reserves of the Company. This announcement of a target dividend for the financial year ending 30 November 2022 should not be taken to imply a profit forecast by the Company.

Enquiries:

Mark Ghahramani                                             

Bellevue Asset Management (UK) Ltd

Tel: +44 (0)20 3871 2862

Brian Smith / Ciara McKillop                  

Company Secretary

PraxisIFM Fund Services (UK) Limited

Tel: +44 (0)20 4513 9260

3 December 2021